表紙:下剤の世界市場:成長、将来展望、競合分析、2024~2032年
市場調査レポート
商品コード
1402952

下剤の世界市場:成長、将来展望、競合分析、2024~2032年

Laxative Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032


出版日
ページ情報
英文 113 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
下剤の世界市場:成長、将来展望、競合分析、2024~2032年
出版日: 2023年12月19日
発行: Acute Market Reports
ページ情報: 英文 113 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

下剤市場は、便秘や関連する胃腸の問題を緩和するために重要な役割を果たしています。下剤市場は、健康意識の高まりとライフスタイルの変化によって、2024~2032年の予測期間中にCAGR 6.1%で成長すると予測されます。2024~2032年までの期間を展望すると、製剤の進歩や適応症の拡大により、市場は進化を続けると予想されます。まとめると、下剤市場は、健康意識の高まり、ライフスタイルの変化、製剤の進歩に牽引され、継続的な成長が見込まれます。副作用の可能性が依然として抑制要因となっています。主要プレーヤーは技術革新と顧客中心戦略を通じて競合優位性を維持し、2023~2032年にかけて売上高が増加すると予測されます。

健康意識の高まり

2023年、下剤市場は、消費者の健康意識の高まりにより大幅な成長を遂げました。全体的な健康のために定期的な排便を維持することの重要性を認識する個人が増加しています。このような意識の高まりにより、便秘やその他の胃腸問題の解決策として下剤の需要が高まっています。健康の重視は、2024~2032年まで主要な促進要因として継続すると予想されます。

ライフスタイルと食生活の変化

ライフスタイルと食生活の変化も市場を牽引しています。座りがちなライフスタイルや食生活の乱れが、便秘や関連疾患の有病率上昇に寄与しています。下剤は、即効性のある便秘解消を求める人々のためのソリューションとなった。このようなライフスタイルの要因が続く中、下剤の需要は伸び続けると予想され、予測期間中のCAGRは高いです。

製剤の進歩

下剤製剤の進歩も重要な促進要因です。市場は、副作用を低減した、より穏やかで効果的な下剤のイントロダクションを示した。経口・直腸用製剤の革新により、使用感が改善され、消費者にとってより魅力的な製剤となった。これらの製剤がさらに進化するにつれて、2024~2032年にかけて高いCAGRで市場成長を牽引すると予想されます。

下剤市場の抑制要因

下剤市場はその成長にもかかわらず、潜在的な副作用に関する抑制要因に直面しています。2023年には、下剤の長期使用による依存性や胃腸障害の可能性に関する懸念が抑制要因として作用しました。こうした副作用は2024~2032年にかけても課題として残ることが予想され、下剤の適切な使用について消費者を教育し、潜在的なリスクを軽減する取り組みが必要となります。

投与経路別市場セグメンテーション:経口の下剤が市場を独占

下剤市場は投与経路別に2つのカテゴリーに分類できる:経口と直腸です。2023年には、便利で広く使用されている経口用下剤が最も高い収益を上げています。しかし、2024~2032年までの予測期間においては、直腸用下剤が最も高いCAGRを示すと予想されます。これらの製剤は特定の症例に的を絞った救済を提供するものであり、人気が高まりそうです。

適応症別市場セグメンテーション:慢性便秘の適応症が市場を独占

もう1つの重要なセグメンテーション要因は、慢性便秘、過敏性腸症候群、その他に分けられる下剤の適応症です。2023年には、慢性便秘の適応症からの売上が最も高かったです。しかし、2024~2032年までの予測期間中、過敏性腸症候群の適応症は、認知度と理解が高まるにつれて、最も高いCAGRを示すと予想されます。

北米が世界のリーダーであり続ける

地域別では、下剤市場は多様な動向を示しています。北米は2023年に最も高い売上比率を記録したが、これは健康意識の高まりとライフスタイル要因によるものです。しかし、アジア太平洋地域は、胃腸の健康に対する意識と下剤へのアクセス性が新興市場で高まることから、2024~2032年にかけて最も高いCAGRを記録すると予想されます。

市場シェア拡大のための研究開発投資

下剤市場は、Bayer AG、GlaxoSmithKline plc、Sanofi、Boehringer Ingelheim Pharmaceuticals Inc.これらの企業は、製剤を改善し市場でのプレゼンスを拡大するために、一貫して研究開発に投資してきました。2023年には大幅な収益を記録しており、2024~2032年にかけても彼らの戦略的投資によって高い収益が見込まれます。主な戦略には、新しい製剤の導入、やさしく効果的なソリューションを強調したマーケティングキャンペーン、流通網の拡大などがあります。

本レポートでお答えする主な質問

下剤市場の成長に影響を与える主なミクロおよびマクロ環境要因は何か?

現在および予測期間中の製品セグメントと地域に関する主な投資ポケットは?

2032年までの推定推計・市場予測

予測期間中に最も速いCAGRを占めるセグメントは?

市場シェアの大きいセグメントとその理由は?

中低所得国は下剤市場に投資しているか?

下剤市場で最大の地域市場はどこか?

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と力学は?

下剤市場の成長を促進する主要動向は?

世界の下剤市場で存在感を高めるための主要な競合企業とその戦略とは?

目次

第1章 序文

  • レポート内容
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

第3章 下剤市場:競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析:2023年 vs 2031年

第4章 下剤市場:マクロ分析と市場力学

  • イントロダクション
  • 世界の下剤市場金額、2021~2031年
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • Porter'sファイブフォースモデル
    • 供給企業の力
    • 買い手の力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 経済情勢
    • 技術情勢
    • 法的情勢
    • 社会的情勢

第5章 下剤市場:投与経路別、2022~2032年

  • 市場概要
  • 成長・収益分析:2023年 vs 2031年
  • 市場セグメンテーション
    • 経口
    • 直腸

第6章 下剤市場:適応症別、2022~2032年

  • 市場概要
  • 成長・収益分析:2023年 vs 2031年
  • 市場セグメンテーション
    • 慢性便秘
    • 過敏性腸症候群
    • その他

第7章 下剤市場:薬剤タイプ別、2022~2032年

  • 市場概要
  • 成長・収益分析:2023年 vs 2031年
  • 市場セグメンテーション
    • 高浸透圧
    • バルク形成
    • 便軟化剤
    • 潤滑剤
    • 刺激剤

第8章 下剤市場:最終用途別、2022~2032年

  • 市場概要
  • 成長・収益分析:2023年 vs 2031年
  • 市場セグメンテーション
    • 病院・クリニック
    • 調査機関
    • その他

第9章 北米の下剤市場、2022~2032年

  • 市場概要
  • 下剤市場:投与経路別、2022~2032年
  • 下剤市場:適応症別、2022~2032年
  • 下剤市場:薬剤タイプ別、2022~2032年
  • 下剤市場:最終用途別、2022~2032年
  • 下剤市場:地域別、2022~2032年
    • 北米
      • 米国
      • カナダ
      • その他の北米

第10章 英国・欧州連合の下剤市場、2022~2032年

  • 市場概要
  • 下剤市場:投与経路別、2022~2032年
  • 下剤市場:適応症別、2022~2032年
  • 下剤市場:薬剤タイプ別、2022~2032年
  • 下剤市場:最終用途別、2022~2032年
  • 下剤市場:地域別、2022~2032年
    • 英国・欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他の英国・欧州連合

第11章 アジア太平洋の下剤市場、2022~2032年

  • 市場概要
  • 下剤市場:投与経路別、2022~2032年
  • 下剤市場:適応症別、2022~2032年
  • 下剤市場:薬剤タイプ別、2022~2032年
  • 下剤市場:最終用途別、2022~2032年
  • 下剤市場:地域別、2022~2032年
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他のアジア太平洋

第12章 ラテンアメリカの下剤市場、2022~2032年

  • 市場概要
  • 下剤市場:投与経路別、2022~2032年
  • 下剤市場:適応症別、2022~2032年
  • 下剤市場:薬剤タイプ別、2022~2032年
  • 下剤市場:最終用途別、2022~2032年
  • 下剤市場:地域別、2022~2032年
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他のラテンアメリカ

第13章 中東・アフリカの下剤市場、2022~2032年

  • 市場概要
  • 下剤市場:投与経路別、2022~2032年
  • 下剤市場:適応症別、2022~2032年
  • 下剤市場:薬剤タイプ別、2022~2032年
  • 下剤市場:最終用途別、2022~2032年
  • 下剤市場:地域別、2022~2032年
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他の中東・アフリカ

第14章 企業プロファイル

  • Bayer AG
  • GlaxoSmithKline plc
  • Sanofi
  • Boehringer Ingelheim Pharmaceuticals Inc.
  • Procter & Gamble Company
  • Purdue Pharma
  • Sucampo Pharmaceuticals Inc.
  • その他の主要企業
図表

List of Tables

  • TABLE 1 Global Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 2 Global Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 3 Global Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 4 Global Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 5 North America Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 6 North America Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 7 North America Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 8 North America Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 9 U.S. Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 10 U.S. Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 11 U.S. Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 12 U.S. Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 13 Canada Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 14 Canada Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 15 Canada Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 16 Canada Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 17 Rest of North America Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 19 Rest of North America Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 20 Rest of North America Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 21 UK and European Union Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 23 UK and European Union Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 24 UK and European Union Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 25 UK Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 26 UK Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 27 UK Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 28 UK Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 29 Germany Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 30 Germany Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 31 Germany Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 32 Germany Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 33 Spain Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 34 Spain Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 35 Spain Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 36 Spain Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 37 Italy Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 38 Italy Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 39 Italy Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 40 Italy Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 41 France Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 42 France Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 43 France Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 44 France Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 45 Rest of Europe Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 47 Rest of Europe Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 48 Rest of Europe Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 49 Asia Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 50 Asia Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 51 Asia Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 52 Asia Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 53 China Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 54 China Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 55 China Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 56 China Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 57 Japan Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 58 Japan Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 59 Japan Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 60 Japan Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 61 India Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 62 India Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 63 India Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 64 India Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 65 Australia Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 66 Australia Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 67 Australia Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 68 Australia Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 69 South Korea Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 70 South Korea Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 71 South Korea Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 72 South Korea Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 73 Latin America Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 74 Latin America Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 75 Latin America Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 76 Latin America Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 77 Brazil Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 78 Brazil Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 79 Brazil Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 80 Brazil Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 81 Mexico Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 82 Mexico Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 83 Mexico Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 84 Mexico Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 85 Rest of Latin America Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 87 Rest of Latin America Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 88 Rest of Latin America Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 89 Middle East and Africa Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 91 Middle East and Africa Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 92 Middle East and Africa Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 93 GCC Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 94 GCC Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 95 GCC Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 96 GCC Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 97 Africa Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 98 Africa Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 99 Africa Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 100 Africa Laxative Market By End Use, 2022-2032, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Laxative Market By Route of Administration, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Laxative Market By Indication, 2022-2032, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Laxative Market By Drug Type, 2022-2032, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Laxative Market By End Use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Laxative Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Laxative Market: Quality Assurance
  • FIG. 5 Global Laxative Market, By Route of Administration, 2023
  • FIG. 6 Global Laxative Market, By Indication, 2023
  • FIG. 7 Global Laxative Market, By Drug Type, 2023
  • FIG. 8 Global Laxative Market, By End Use, 2023
  • FIG. 9 Global Laxative Market, By Geography, 2023
  • FIG. 10 Market Geographical Opportunity Matrix - Global Laxative Market, 2023

FIG. 11Market Positioning of Key Laxative Market Players, 2023

FIG. 12Global Laxative Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2031

  • FIG. 13 Global Laxative Market, By Route of Administration, 2023 Vs 2032, %
  • FIG. 14 Global Laxative Market, By Indication, 2023 Vs 2032, %
  • FIG. 15 Global Laxative Market, By Drug Type, 2023 Vs 2032, %
  • FIG. 16 Global Laxative Market, By End Use, 2023 Vs 2032, %
  • FIG. 17 U.S. Laxative Market (US$ Million), 2022 - 2032
  • FIG. 18 Canada Laxative Market (US$ Million), 2022 - 2032
  • FIG. 19 Rest of North America Laxative Market (US$ Million), 2022 - 2032
  • FIG. 20 UK Laxative Market (US$ Million), 2022 - 2032
  • FIG. 21 Germany Laxative Market (US$ Million), 2022 - 2032
  • FIG. 22 Spain Laxative Market (US$ Million), 2022 - 2032
  • FIG. 23 Italy Laxative Market (US$ Million), 2022 - 2032
  • FIG. 24 France Laxative Market (US$ Million), 2022 - 2032
  • FIG. 25 Rest of Europe Laxative Market (US$ Million), 2022 - 2032
  • FIG. 26 China Laxative Market (US$ Million), 2022 - 2032
  • FIG. 27 Japan Laxative Market (US$ Million), 2022 - 2032
  • FIG. 28 India Laxative Market (US$ Million), 2022 - 2032
  • FIG. 29 Australia Laxative Market (US$ Million), 2022 - 2032
  • FIG. 30 South Korea Laxative Market (US$ Million), 2022 - 2032
  • FIG. 31 Rest of Asia Laxative Market (US$ Million), 2022 - 2032
  • FIG. 32 Brazil Laxative Market (US$ Million), 2022 - 2032
  • FIG. 33 Mexico Laxative Market (US$ Million), 2022 - 2032
  • FIG. 34 Rest of Latin America Laxative Market (US$ Million), 2022 - 2032
  • FIG. 35 GCC Laxative Market (US$ Million), 2022 - 2032
  • FIG. 36 Africa Laxative Market (US$ Million), 2022 - 2032
  • FIG. 37 Rest of Middle East and Africa Laxative Market (US$ Million), 2022 - 2032
目次
Product Code: 136723-12-23

The laxative market plays a crucial role in providing relief from constipation and related gastrointestinal issues. The laxative market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032, driven by increasing health awareness and changing lifestyles. Looking ahead to the period from 2024 to 2032, the market is expected to continue evolving with advancements in formulations and a broader range of indications. In summary, the laxative market is poised for continued growth, driven by increasing health awareness, changing lifestyles, and advancements in formulations. Potential side effects remain a restraint. Key players are expected to maintain their competitive edge through innovation and customer-centric strategies, with revenues projected to rise from 2023 to 2032.

Increasing Health Awareness

 In 2023, the laxative market witnessed substantial growth due to the increasing health awareness among consumers. More individuals are recognizing the importance of maintaining regular bowel movements for overall well-being. This growing awareness led to higher demand for laxatives as a solution for constipation and other gastrointestinal issues. The emphasis on health is expected to continue as a key driver from 2024 to 2032.

Changing Lifestyles and Dietary Habits

The market was also driven by changing lifestyles and dietary habits. Sedentary lifestyles and poor dietary choices have contributed to an increased prevalence of constipation and related conditions. laxatives became a go-to solution for individuals seeking quick relief. As these lifestyle factors persist, the demand for laxatives is expected to continue growing, contributing to a high CAGR during the forecast period.

Advancements in Formulations

Another significant driver was advancements in laxative formulations. The market witnessed the introduction of more gentle and effective laxatives with reduced side effects. Innovations in oral and rectal formulations improved the user experience, making them more attractive to consumers. As these formulations evolve further, they are expected to drive market growth with a high CAGR from 2024 to 2032.

Restraint in the Laxative Market

Despite its growth, the laxative market faces a restraint related to potential side effects. In 2023, concerns about the potential for dependency and gastrointestinal issues with long-term laxative use acted as a restraint. These side effects are expected to remain a challenge from 2024 to 2032, necessitating efforts to educate consumers on the proper use of laxatives and mitigate potential risks.

Market Segmentation by Route of Administration: Oral laxatives Dominate the Market

The laxative market can be segmented by route of administration into two categories: Oral and Rectal. In 2023, the highest revenue was attributed to oral laxatives, which are convenient and widely used. However, during the forecast period from 2024 to 2032, rectal laxatives are expected to exhibit the highest CAGR. These formulations offer targeted relief for specific cases and are likely to gain popularity.

Market Segmentation by Indication: Chronic Constipation indication Dominates the Market

Another crucial segmentation factor is the indication for laxative use, which can be divided into Chronic Constipation, Irritable Bowel Syndrome, and Others. In 2023, the highest revenue came from the Chronic Constipation indication, as it represents a common and recurring condition. However, during the forecast period from 2024 to 2032, the irritable bowel syndrome indication is expected to exhibit the highest CAGR, as it gains more recognition and understanding.

North America Remains the Global Leader

Geographically, the laxative market exhibits diverse trends. North America recorded the highest revenue percentage in 2023, driven by increased health consciousness and lifestyle factors. However, the Asia-Pacific region is expected to have the highest CAGR from 2024 to 2032, as awareness of gastrointestinal health and accessibility to laxatives grow in emerging markets.

R&D Investment to Enhance the Market Share

The laxative market is characterized by competition among key players, such as Bayer AG, GlaxoSmithKline plc, Sanofi, Boehringer Ingelheim Pharmaceuticals Inc., Procter & Gamble Company, Purdue Pharma, and Sucampo Pharmaceuticals Inc. These companies have consistently invested in research and development to improve laxative formulations and expand their market presence. In 2023, they recorded substantial revenues, and it is expected that their strategic investments will continue to yield high returns from 2024 to 2032. Key strategies include introducing new formulations, marketing campaigns emphasizing gentle and effective solutions, and expanding distribution networks.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofLaxative market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Laxative market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Route of Administration

    • Oral
    • Rectal

Indication

    • Chronic Constipation
    • Irritable Bowel Syndrome
    • Others

Drug Type

    • Hyperosmotic
    • Bulk-Forming
    • Stool Softeners
    • Lubricants
    • Stimulants

End Use

    • Hospitals & Clinics
    • Research Institutes
    • Others

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Laxative market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Laxative market?

Which is the largest regional market for Laxative market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Laxative market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Laxative market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Laxative Market
  • 2.2. Global Laxative Market, By Route of Administration, 2023 (US$ Million)
  • 2.3. Global Laxative Market, By Indication, 2023 (US$ Million)
  • 2.4. Global Laxative Market, By Drug Type, 2023 (US$ Million)
  • 2.5. Global Laxative Market, By End Use, 2023 (US$ Million)
  • 2.6. Global Laxative Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Laxative Market: Competitive Analysis

  • 3.1. Market Positioning of Key Laxative Market Vendors
  • 3.2. Strategies Adopted by Laxative Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2031

4. Laxative Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Laxative Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Laxative Market: By Route of Administration, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Oral
    • 5.3.2. Rectal

6. Laxative Market: By Indication, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Chronic Constipation
    • 6.3.2. Irritable Bowel Syndrome
    • 6.3.3. Others

7. Laxative Market: By Drug Type, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hyperosmotic
    • 7.3.2. Bulk-Forming
    • 7.3.3. Stool Softeners
    • 7.3.4. Lubricants
    • 7.3.5. Stimulants

8. Laxative Market: By End Use, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Research Institutes
    • 8.3.3. Others

9. North America Laxative Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
  • 9.3. Laxative Market: By Indication, 2022-2032, USD (Million)
  • 9.4. Laxative Market: By Drug Type, 2022-2032, USD (Million)
  • 9.5. Laxative Market: By End Use, 2022-2032, USD (Million)
  • 9.6.Laxative Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 9.6.1.1.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.1.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 9.6.1.1.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 9.6.1.2.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.2.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 9.6.1.2.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 9.6.1.3.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.3.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 9.6.1.3.4. Laxative Market: By End Use, 2022-2032, USD (Million)

10. UK and European Union Laxative Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
  • 10.3. Laxative Market: By Indication, 2022-2032, USD (Million)
  • 10.4. Laxative Market: By Drug Type, 2022-2032, USD (Million)
  • 10.5. Laxative Market: By End Use, 2022-2032, USD (Million)
  • 10.6.Laxative Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 10.6.1.1.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.1.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 10.6.1.1.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 10.6.1.2.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.2.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 10.6.1.2.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 10.6.1.3.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.3.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 10.6.1.3.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 10.6.1.4.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.4.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 10.6.1.4.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 10.6.1.5.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.5.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 10.6.1.5.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 10.6.1.6.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.6.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 10.6.1.6.4. Laxative Market: By End Use, 2022-2032, USD (Million)

11. Asia Pacific Laxative Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
  • 11.3. Laxative Market: By Indication, 2022-2032, USD (Million)
  • 11.4. Laxative Market: By Drug Type, 2022-2032, USD (Million)
  • 11.5. Laxative Market: By End Use, 2022-2032, USD (Million)
  • 11.6.Laxative Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 11.6.1.1.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.1.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 11.6.1.1.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 11.6.1.2.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.2.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 11.6.1.2.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 11.6.1.3.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.3.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 11.6.1.3.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 11.6.1.4.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.4.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 11.6.1.4.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 11.6.1.5.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.5.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 11.6.1.5.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 11.6.1.6.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.6.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 11.6.1.6.4. Laxative Market: By End Use, 2022-2032, USD (Million)

12. Latin America Laxative Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
  • 12.3. Laxative Market: By Indication, 2022-2032, USD (Million)
  • 12.4. Laxative Market: By Drug Type, 2022-2032, USD (Million)
  • 12.5. Laxative Market: By End Use, 2022-2032, USD (Million)
  • 12.6.Laxative Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 12.6.1.1.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.1.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 12.6.1.1.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 12.6.1.2.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.2.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 12.6.1.2.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 12.6.1.3.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.3.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 12.6.1.3.4. Laxative Market: By End Use, 2022-2032, USD (Million)

13. Middle East and Africa Laxative Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
  • 13.3. Laxative Market: By Indication, 2022-2032, USD (Million)
  • 13.4. Laxative Market: By Drug Type, 2022-2032, USD (Million)
  • 13.5. Laxative Market: By End Use, 2022-2032, USD (Million)
  • 13.6.Laxative Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 13.6.1.1.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.1.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 13.6.1.1.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 13.6.1.2.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.2.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 13.6.1.2.4. Laxative Market: By End Use, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Laxative Market: By Route of Administration, 2022-2032, USD (Million)
        • 13.6.1.3.2. Laxative Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.3.3. Laxative Market: By Drug Type, 2022-2032, USD (Million)
        • 13.6.1.3.4. Laxative Market: By End Use, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Bayer AG
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. GlaxoSmithKline plc
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Sanofi
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Boehringer Ingelheim Pharmaceuticals Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Procter & Gamble Company
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Purdue Pharma
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Sucampo Pharmaceuticals Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Other Notable Players
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives